Press Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel OK

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel OK

Get News Alerts by Email

Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• Sep 12, 2022

  Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates
• Sep 10, 2022

  Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022
• Sep 8, 2022

  Cardiff Oncology to Present at Upcoming Investor Conferences in September
• Sep 6, 2022

  Cardiff Oncology Announces Upcoming Poster Presentations at the ESMO Congress 2022
• Aug 29, 2022

  Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022

Show 5102550100 per page